FOXA2 and Hepatic steatosis: p300 can acetylate FOXA2, thereby blocking its nuclear rejection and increasing its transcriptional activity, which further led to increased mitochondrial oxidation, hepatic ketogenesis, insulin sensitivity and attenuated hepatic steatosis in db/db mice.